[1]
|
Buskwofie, A., David-West, G. and Clare, C.A. (2020) A Review of Cervical Cancer: Incidence and Disparities. Journal of the National Medical Association, 112, 229-232. https://doi.org/10.1016/j.jnma.2020.03.002
|
[2]
|
Huang, J., Luo, F., Shi, M., Luo, J., Ma, C., Li, S., et al. (2021) Construction and Validation of a Metabolic Gene-Associated Prognostic Model for Cervical Carcinoma and the Role on Tumor Microenvironment and Immunity. Aging, 13, 25072- 25088. https://doi.org/10.18632/aging.203723
|
[3]
|
Garrido, F., Wild, C.M., Mittelberger, J., Dobler, F., Schneider, M., Ansorge, N., et al. (2021) The Role of Chemokines in Cervical Cancers. Medicina, 57, Article No. 1141. https://doi.org/10.3390/medicina57111141
|
[4]
|
Jamiyan, T., Kuroda, H., Yamaguchi, R., Abe, A. and Hayashi, M. (2020) CD68- and CD163-Positive Tumor-Associated Macrophages in Triple Negative Cancer of the Breast. Virchows Archiv, 477, 767-775.
https://doi.org/10.1007/s00428-020-02855-z
|
[5]
|
Wangmo, D., Premsrirut, P.K., Yuan, C., Morris, W.S., Zhao, X. and Subramanian, S. (2021) ACKR4 in Tumor Cells Regulates Dendritic Cell Migration to Tumor-Draining Lymph Nodes and T-Cell Priming. Cancers, 13, Article No. 5021. https://doi.org/10.3390/cancers13195021
|
[6]
|
Zhang, L., Mao, Z., Lai, Y., Wan, T., Zhang, K., Zhou, B., et al. (2020) A Review of the Research Progress in T-Lymphocyte Im-munity and Cervical Cancer. Translational Cancer Research, 9, 2026-2036.
https://doi.org/10.21037/tcr.2020.01.33
|
[7]
|
Tao, L., Liu, S., Xiong, J., Yang, H., Wu, Y. and Xu, A. (2021) IL-1β Promotes Cervical Cancer through Activating NF-κB/CCL-2. International Journal of Clinical and Experimental Pa-thology, 14, 426-433.
|
[8]
|
Halle, M.K., Munk, A.C., Engesæter, B., Akbari, S., Frafjord, A., Hoivik, E.A., et al. (2021) A Gene Signature Identifying CIN3 Regression and Cervical Cancer Survival. Cancers, 13, Article No. 5737.
https://doi.org/10.3390/cancers13225737
|
[9]
|
Karin, N. (2021) Chemokines in the Landscape of Cancer Immuno-therapy: How They and Their Receptors Can Be Used to Turn Cold Tumors into Hot Ones? Cancers, 13, Article No. 6317. https://doi.org/10.3390/cancers13246317
|
[10]
|
Jiang, Y. and Chen, S. (2022) Functional New Transcription Factors (TFs) Associated with Cervical Cancer. Journal of Healthcare Engineering, 2022, Article ID: 8381559. https://doi.org/10.1155/2022/8381559
|
[11]
|
Kobari, L., Auclair, M., Piau, O., Ferrand, N., Zaoui, M., Delhommeau, F., et al. (2022) Circulating Cytokines Present in Multiple Myeloma Patients Inhibit the Osteoblastic Differentiation of Adipose Stem Cells. Leukemia, 36, 540-548.
https://doi.org/10.1038/s41375-021-01428-6
|
[12]
|
Tuong, Z.K., Lukowski, S.W., Nguyen, Q.H., Chandra J, Zhou C, Gillinder K, et al. (2021) A Model of Impaired Langerhans Cell Maturation Associated with HPV Induced Epithelial Hyperplasia. iScience, 24, Article ID: 103326.
https://doi.org/10.1016/j.isci.2021.103326
|
[13]
|
Sharma, P.C. and Gupta, A. (2020) MicroRNAs: Potential Bi-omarkers for Diagnosis and Prognosis of Different Cancers. Translational Cancer Research, 9, 5798-5818. https://doi.org/10.21037/tcr-20-1294
|
[14]
|
Yang, Y., Ding, R. and Wang, R. (2022) Identification of Candidate Targets and Mechanisms Involved in miRNA Regulation in Multiple Myeloma. World Journal of Surgical Oncology, 20, Article No. 23.
https://doi.org/10.1186/s12957-021-02482-1
|
[15]
|
Kfoury, Y., Baryawno, N., Severe, N., Mei, S., Gustafsson, K., Hirz, T., et al. (2021) Human Prostate Cancer Bone Metastases Have an Actionable Immunosuppressive Microenviron-ment. Cancer Cell, 39, 1464-1478.e8.
https://doi.org/10.1016/j.ccell.2021.09.005
|
[16]
|
Wang, Q., Schmoeckel, E., Kost, B.P., Kuhn, C., Vattai, A., Vils-maier, T., et al. (2019) Higher CCL22+ Cell Infiltration Is Associated with Poor Prognosis in Cervical Cancer Patients. Cancers, 11, Article No. 2004.
https://doi.org/10.3390/cancers11122004
|
[17]
|
Pannunzio, A. and Coluccia, M. (2018) Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature. Pharmaceuticals, 11, Arti-cle No. 101.
https://doi.org/10.3390/ph11040101
|
[18]
|
Zhang, W., Wu, Q., Wang, C., Yang, L., Liu, P. and Ma, C. (2018) AKIP1 Promotes Angiogenesis and Tumor Growth by Upregulating CXC-Chemokines in Cervical Cancer Cells. Molec-ular and Cellular Biochemistry, 448, 311-320.
https://doi.org/10.1007/s11010-018-3335-7
|
[19]
|
Qi, Y.L., Li, Y., Man, X.X., Sui, H.Y., Zhao, X.L., Zhang, P.X., et al. (2020) CXCL3 Overexpression Promotes the Tumorigenic Potential of Uterine Cervical Cancer Cells via the MAPK/ERK Pathway. Journal of Cellular Physiology, 235, 4756-4765. https://doi.org/10.1002/jcp.29353
|
[20]
|
Feng, X., Zhang, D., Li, X., Ma, S., Zhang, C., Wang, J., et al. (2018) CXCL5, the Upregulated Chemokine in Patients with Uterine Cervix Cancer, in Vivo and in Vitro Contributes to Onco-genic Potential of Hela Uterine Cervix Cancer Cells. Biomedicine & Pharmacotherapy, 107, 1496-1504. https://doi.org/10.1016/j.biopha.2018.08.149
|
[21]
|
Bai, L., Yao, N., Qiao, G., Wu, L. and Ma, X. (2020) CXCL5 Contributes to the Tumorigenicity of Cervical Cancer and Is Post-Transcriptionally Regulated by miR-577. International Journal of Clinical and Experimental Pathology, 13, 2984-2993.
|
[22]
|
Shen, W., Xie, X.Y., Liu, M.R. and Wang, L.L. (2019) MicroRNA-101-5p Inhibits the Growth and Metastasis of Cervical Cancer Cell by Inhibiting CXCL6. European Review for Medical and Pharmacological Sciences, 23, 1957-1968.
|
[23]
|
Gu, L., Yao, Y. and Chen, Z. (2021) An In-ter-Correlation among Chemokine (C-X-C Motif) Ligand (CXCL) 1, CXCL2 and CXCL8, and Their Diversified Poten-tial as Biomarkers for Tumor Features and Survival Profiles in Non-Small Cell Lung Cancer Patients. Translational Cancer Research, 10, 748-758.
https://doi.org/10.21037/tcr-20-2539
|
[24]
|
Ding, H.M., Zhang, H., Wang, J., Zhou, J.H., Shen, F.R., Ji, R.N., et al. (2021) miR-302c-3p and miR-520a-3p Suppress the Proliferation of Cervical Carcinoma Cells by Targeting CXCL8. Molecular Medicine Reports, 23, Article No. 322. https://doi.org/10.3892/mmr.2021.11961
|
[25]
|
Li, X., Zhong, Q., Luo, D., Du, Q. and Liu, W. (2019) The Prognostic Value of CXC Subfamily Ligands in Stage I-III Patients with Colo-rectal Cancer. PLOS ONE, 14, Article ID: e0214611. https://doi.org/10.1371/journal.pone.0214611
|
[26]
|
Chen, X., He, H., Xiao, Y., Hasim, A., Yuan, J., Ye, M., et al. (2021) CXCL10 Produced by HPV-Positive Cervical Cancer Cells Stimulates Exosomal PDL1 Expression by Fibroblasts via CXCR3 and JAK-STAT Pathways. Frontiers in Oncology, 11, Article ID: 629350. https://doi.org/10.3389/fonc.2021.629350
|
[27]
|
Fujimoto, N. and Dieterich, L.C. (2021) Mechanisms and Clinical Significance of Tumor Lymphatic Invasion. Cells, 10, Article No. 2585. https://doi.org/10.3390/cells10102585
|
[28]
|
Oany, A.R., Mia, M., Pervin, T., Alyami, S.A. and Moni, M.A. (2021) Integrative Systems Biology Approaches to Identify Potential Biomarkers and Pathways of Cervical Cancer. Journal of Personalized Medicine, 11, Article No.363.
https://doi.org/10.3390/jpm11050363
|
[29]
|
Kong, W., Zhao, G., Chen, H., Wang, W., Shang, X., Sun, Q., et al. (2021) Analysis of Therapeutic targets and Prognostic Biomarkers of CXC Chemokines in Cervical Cancer Microenvi-ronment. Cancer Cell International, 21, Article No. 399. https://doi.org/10.1186/s12935-021-02101-9
|
[30]
|
Ma, D., Fan, S.B., Hua, N., Li, G.H., Chang, Q. and Liu, X. (2020) Hypermethylation of Single CpG Dinucleotides at the Pro-moter of CXCL13 Gene Promoting Cell Migration in Cervical Cancer. Current Cancer Drug Targets, 20, 355-363.
https://doi.org/10.2174/1568009620666200102123635
|